GlaxoSmithKline plc CEDEAR (GSK)
BCBA
Closed
Aug 21, 2026
Day's Range
20,450.0052 wk Range
12,975.00Overview - GSK - GlaxoSmithKline plc CEDEAR
Key Statistics
Valuation
Enterprise Value
85,649.78T
P/E (Trailing)
‪17.39‬
PEG Ratio
‪-0.24‬
Price / Sales (TTM)
‪5,045.16‬
Price / Book
‪1.17‬
EV / EBITDA
‪3,873.90‬
Profitability
Gross Margin
‪73.05%‬
Profit Margin
‪14.52%‬
Operating Margin
‪30.94%‬
Return on Assets
‪10.00%‬
Return on Equity
‪33.38%‬
Ownership
Shares Outstanding
4.00B
Float
1.94B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.29‬
50-Day Avg
‪20,313.40‬
200-Day Avg
‪19,751.65‬
Dividends
Payout Ratio
‪56.79%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - GSK - GlaxoSmithKline plc CEDEAR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- GSKBCBAGlaxoSmithKline plc CEDEAR167.51TMarket Cap+35.56%52-week change17.31P/E (Trailing)‪14.52%‬Profit Margin
- SANBCBABanco Santander, S.A. CEDEAR1,355.89TMarket Cap+43.62%52-week change60.24P/E (Trailing)‪33.46%‬Profit Margin
- JNJBCBAJohnson & Johnson CEDEAR345.82TMarket Cap+43.38%52-week change11.12P/E (Trailing)‪21.48%‬Profit Margin
- AZNBCBAAstraZeneca PLC CEDEAR101.00TMarket Cap+18.54%52-week change6.36P/E (Trailing)‪17.02%‬Profit Margin
- ABBVBCBAAbbVie Inc. - Depositary Receipt74.64TMarket Cap+33.95%52-week change7.75P/E (Trailing)‪9.80%‬Profit Margin
- BMYBCBABristol-Myers Squibb Co.72.76TMarket Cap+40.06%52-week change5.24P/E (Trailing)‪18.87%‬Profit Margin
- GILDBCBAGilead Sciences Inc.72.10TMarket Cap+33.02%52-week change4.84P/E (Trailing)‪-10.63%‬Profit Margin
Profile Summary - GSK - GlaxoSmithKline plc CEDEAR
About
GlaxoSmithKline plc CEDEAR is a depositary receipt representing shares of GlaxoSmithKline plc, a leading global pharmaceutical and healthcare company. CEDEARs (Certificados de Depósito Argentinos) enable Argentine investors to access foreign securities, allowing them to participate in the performance of major…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
